Qcare Site Services Inc

1. Moderna TX, Inc. $7,988,205 862 payments
2. Pfizer Inc. $3,350,438 474 payments
3. AstraZeneca Pharmaceuticals LP $2,469,277 81 payments
4. Regeneron Pharmaceuticals, Inc. $1,888,985 268 payments
5. AbbVie, Inc. $1,237,945 325 payments
6. Sanofi US Services Inc. $626,696 113 payments
7. Astellas Pharma Global Development $479,122 44 payments
8. Emergent BioSolutions Inc. $478,915 302 payments
9. Eli Lilly and Company $425,881 17 payments
10. Genentech, Inc. $403,443 113 payments

1. A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ?60 Years of Age $2,660,842 76 payments
2. A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis $2,654,081 356 payments
3. A Randomized, Double-Blind Study of The Efficacy and Safety of Trevogrumab, With or Without Garetosmab, in Addition to Semaglutide in Patients With Obesity $1,558,767 197 payments
4. A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age $790,134 83 payments
5. A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age $641,851 29 payments
6. A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event $617,405 18 payments
7. A Phase 3 Randomized Doubleblinded Placebocontrolled Trial to Evaluate the Efficacy and Safety of A Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy $576,833 54 payments
8. A Phase 1 Randomized and Phase 2 Study to Evaluate the Safety Tolerability Immunogenicity and Immunopersistence of A Clostridioides Difficile Vaccine Administered in A 2Dose Regimen With Novel Adjuvants in Healthy Adults $568,478 26 payments
9. A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ?12 Years of Age to Prevent COVID-19 $545,755 199 payments
10. A Phase 2 Placebocontrolled Randomized Proof of Concept Study of A Respiratory Syncytial Virus RSV Vaccine in Pregnant Women $480,184 42 payments

1. Other $120,038 3 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.